JP Morgan Chase
CNTB

JP Morgan Chase’s Connect Biopharma Holdings CNTB Stock Holding History

JP Morgan Chase’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$351 Hold
121
– – ﹤0.01% 7210
2025
Q4 		$341 Hold
121
– – ﹤0.01% 7113
2025
Q3 		$179 Hold
121
– – ﹤0.01% 7124
2025
Q2 		$121 Hold
121
– – ﹤0.01% 6817
2025
Q1 		$67 Hold
121
– – ﹤0.01% 6931
2024
Q4 		$167 Hold
121
– – ﹤0.01% 6935
2024
Q3 		$172 Hold
121
– – ﹤0.01% 6922
2024
Q2 		$184 Hold
121
– – ﹤0.01% 6798
2024
Q1 		$211 Hold
121
– – ﹤0.01% 6803
2023
Q4 		$143 Sell
121
-23,411
-99% -$27.8K ﹤0.01% 7087
2023
Q3 		$18.2K Sell
23,532
-24,840
-51% -$22.6K ﹤0.01% 6092
2023
Q2 		$53.7K Sell
48,372
-30,175
-38% -$33.8K ﹤0.01% 5696
2023
Q1 		$79K Buy
78,547
+72,987
+1,313% +$79.6K ﹤0.01% 5530
2022
Q4 		$4K Buy
5,560
+2,490
+81% +$2.05K ﹤0.01% 6191
2022
Q3 		$4K Buy
3,070
+2,818
+1,118% +$3.39K ﹤0.01% 6128
2022
Q2 		$0 Sell
252
-3,668
-94% -$5.4K ﹤0.01% 6511
2022
Q1 		$12K Buy
3,920
+1,052
+37% +$4.44K ﹤0.01% 6172
2021
Q4 		$15K Buy
+2,868
New +$31.9K ﹤0.01% 6267

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

JP Morgan Chase's CNTB Position: Q1 2026 in Review

JP Morgan Chase held its Connect Biopharma Holdings (CNTB) position steady in Q1 2026 at 121 shares worth $351. The position accounts for ﹤0.01% of the portfolio, ranked #7210.

JP Morgan Chase first reported a position in CNTB in Q4 2021 and has held it in 18 quarters since. The position peaked at $79K in Q1 2023. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • JP Morgan Chase held 121 shares of Connect Biopharma Holdings worth $351 as of Q1 2026.
  • JP Morgan Chase left its Connect Biopharma Holdings share count unchanged in Q1 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7210 holding.
  • JP Morgan Chase first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 18 quarters since.
  • JP Morgan Chase's Connect Biopharma Holdings position peaked at $79K in Q1 2023.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.